U.S. Vaccine Supply: What to Know

January 21, 2021 ☼ bidenpandemic

Source: The New York Times - Link

Although the Trump administration was criticized for not using the Defense Production Act more aggressively to ramp up production of testing supplies and protective gear, it did use the act many times to give vaccine manufacturers priority access to suppliers of raw ingredients and equipment.

In a plan released on Thursday, the Biden administration indicated it would continue to use the act to boost supplies needed for vaccine manufacturing, as well as other materials that are required to immunize tens of millions of people. Although the plan provided few details, one example cited is increasing production of a special syringe that can squeeze six doses out of Pfizer vials that were originally intended to contain five.

Sometimes it’s all in the details. There is never one solution to a problem. You have to pull all the levers and some of them won’t amount to much. Every little bit will help.